ADX-2191 is a preservative-free intravitreal formulation of methotrexate designed to treat various rare retinal diseases such as retinitis pigmentosa.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for ADX-2191 (methotrexate intravitreal ...

Experts disagree on best strategies to prevent a rare, devastating complication: when patients with diffuse large B-cell ...

A cross-sectional study of RA patients in India finds 34.5% suffer from methotrexate intolerance, with symptoms often ...

Aldeyra Therapeutics received FDA fast track designation for ADX-2191 for the treatment of retinitis pigmentosa, according to ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Dozens of women in states including Texas, Alabama, Georgia, South Carolina, and Tennessee also have had problems getting their methotrexate, either because of issues at pharmacies or because they ...

Methotrexate is often used to treat rheumatoid arthritis, Crohn's disease and cancer. But it can also be used to terminate nonviable pregnancies, where a fertilized egg grows outside the womb.

Methotrexate helped her psoriasis clear up, reduced her joint pain, and allowed her to resume her life. She’d never had a problem having the prescription filled until after the Dobbs decision.

The utility of GVHD prophylaxis with cyclosporin, MTX and prednisolone (CSA/MTX/Pred) in allogeneic PBPC transplants is not well described although there are published data using this combination ...

January 28, 2008 — New research shows that high-dose methotrexate is the most effective drug for primary central nervous system lymphoma (PCNSL), with up to 20% of patients achieving a long-term ...